UAE approves Sinopharm’s new protein vaccine as booster dose starting 2022

Estimated read time 5 min read

[vc_row el_class=”container section”][vc_column el_class=”row”][vc_row_inner el_class=”row”][vc_column_inner][expatmedia-landing-article title=”landing article”][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”col-md-8 “][vc_column_inner el_class=”col-md-8″][expatmedia-article-content body_text=”Nothing, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.

Consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.” byline=”staff reporter”]

UAE approves Sinopharm’s new protein vaccine as booster dose starting 2022

 

DUBAI – The Ministry of Health and Prevention has approved the emergency use of a new Sinopharm protein vaccine, which will be available to the public starting in January.

The Sinopharm CNBG recombinatant protein vaccine is approved for emergency use in the UAE following strict monitoring and evaluation of a study conducted in the emirates.

The vaccine will be available to the public as a booster dose starting January 2022 as part of the measures taken to contain the virus spread.

According to the Ministry of Health and Prevention, vaccine test subjects in the UAE showed improved immune capacity against the SARS-CoV-2 variants.

Volunteers for the new vaccine—who previously received two doses of the Sinopharm inactivated vaccine—also showed immune response against emerging coronavirus variants.

Participants who received the new Sinopharm protein vaccine developed up to 100 percent of neutralising antibodies, and did not experience any side effects.

The ministry affirmed that the emergency use of the new vaccine is in full compliance with the regulations and laws for a faster review of licencing procedures.

The new vaccine tested with a high safety rate that allows rapid production and easy storage and distribution.

The new vaccine will be produced and distributed by Hayat Biotech, a joint venture between G42 and Sinopharm CNBG. ICA/Expat Media


For all the latest news from the UAE and the world, follow us on Facebook, Twitter and Instagram and subscribe to our YouTube page[/expatmedia-article-content][/vc_column_inner][vc_column_inner][expatmedia-related-posts enable_pagination=”no” layout=”2-col” posts_query=”size:6|order_by:date|post_type:post|categories:35″ title=”More Society Stories” thumb_size=”expatmedia-post-thumbnail”][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”col-md-4″][vc_column_inner][expatmedia-latest-posts read_more_text=”Read more →” posts_query=”size:10|order_by:date|post_type:post” title=”LATEST NEWS”][/vc_column_inner][vc_column_inner el_class=”border-box border-box-mwidth business–popular-ad”][expatmedia-guides-posts posts_query=”size:3|order_by:date|post_type:post|categories:35″ title=”POPULAR IN SOCIETY”][/vc_column_inner][vc_column_inner][expatmedia-html custom_content=”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”][expatmedia-subscription title=”Subscribe”][/vc_column_inner][vc_column_inner el_class=”border-box border-box-mwidth business–popular-ad”][expatmedia-guides-posts page_link=”http://expatmedia.net/guides/” posts_query=”size:3|order_by:date|post_type:post|categories:2″ title=”Guides”][/vc_column_inner][vc_column_inner][svc_social_stream twitter_type=”@” twitter_num=”4″ skin_type=”template” grid_columns_count_for_desktop=”vcyt-col-md-12″ grid_columns_count_for_tablet=”vcyt-col-sm-12″ grid_columns_count_for_mobile=”vcyt-col-xs-12″ excerpt_length=”150″ loadmore=”no” title=”Twitter Post” twitter_id=”ExpatMediaUAE”][vc_raw_html]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[/vc_raw_html][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]

You May Also Like

More Stories

+ There are no comments

Add yours